Moderna's experimental coronavirus vaccine gets FDA's 'fast track' status

Moderna's experimental coronavirus vaccine gets FDA's 'fast track' status

Reuters

Published

Moderna Inc said on Tuesday its experimental coronavirus vaccine had gained the U.S. Food and Drug Administration's "fast track" designation.

Full Article